Shimon Slavin
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Shimon Slavin | |
|---|---|
 | |
| Born | May 17, 1941 |
| Education | Hebrew University of Jerusalem
Stanford University School of Medicine Fred Hutchinson Cancer Research Center |
| Medical career | |
| Profession | Physician |
| Sub-specialties | Immunology, cancer immunotherapy |
Shimon Slavin (Hebrew: שמעון סלוין; born 17 May 1941) is an Israeli professor of medicine. Born in Tel Aviv, he moved to Jerusalem with his family in 1946, and resided there until 2007.
In 2016, Slavin contributed to other Hadassah Medical Center doctors' efforts of transplantation of stem cells. That same year, International Center for Cell Therapy & Cancer Immunotherapy (CTCI), of which Slavin served as the medical and scientific director, was closed down by Israeli government. His medical license was suspended for six months by the Ministry of Health in 2017, and for another entire year in January 2018. In the latter decision, judge Amnon Strashnov found Slavin to have violated medical ethics and medical law, commented on the previous 6-month suspension as "too far [...] in favor of the defendant [Slavin]", and describing him as committing "serious negligence in fulfilling his duties as a doctor", and that "his greatness is matched only by the depth of his fall". In the same investigation, it was revealed that two patients died after receiving treatment at the clinic.
Published works
Books
- Bone Marrow and Organ Transplantation: Achievements and Goals. Elsevier. 1984. ISBN 9780444805560.
- Tolerance in Bone Marrow and Organ Transplantation: Achievements and Goals. Elsevier. 1985. ISBN 9780444805577.
- The Radiological Accident in Soreq. International Atomic Energy Agency. 1993. ISBN 9789201016935.
- Non-myeloablative Stem Cell Transplantation (NST). New Frontiers in Cancer Therapy. Darwin Scientific Publishing Ltd. 2000. ISBN 9781903557006.
See also
References
- ↑ Stem cell therapy trial for ALS and MS patients at Jerusalem hospital shows stunning results
- ↑ "Ex-Hadassah head of bone-marrow transplants loses license for 6 months". The Jerusalem Post. 2017-06-19. Retrieved 2026-03-09.
The Health Ministry suspended for at least six months the license of Prof. Shimon Slavin, the much-celebratad former head of bone-marrow transplantation at Hadassah University Medical Center, who retired in 2007 and set up a private clinic in Tel Aviv. [...] Last year, the ministry ordered the closure of the International Center for Cellular Medicine and Cancer Immunotherapy, a private medical institution in Tel Aviv's Palace Tower run by Slavin. The ministry's Tel Aviv District health officer, Dr. Rivka Sheffer, wrote to Slavin with copies to the Israel Police, the ministry's director-general, its legal adviser and other officials, that what was going on in Slavin's clinic "was not for the good of the health of patients there."
- 1 2 "Suspension of Prof. Shimon Slavin's License". www.gov.il. 2018-02-01. Retrieved 2026-10-06.
[From] January 29, 2018 to suspend the license of Prof. Shimon Slavin for a period of one year. [This] results from a plea-bargain agreement between the parties, where a confession to the crimes in the revised combined complaint was received and both sides argued for disciplinary action of license suspension. [Between] the years 2013-2016 [...] Slavin carried out innovative and experimental treatments on patients with malignant diseases and auto-immune diseases, without having the appropriate permits and in contradiction to the Public Health Ordinance (Medical Experiments on Humans) [...] concerning two patients who died after receiving treatment at the clinic, the Director General decided on June 13, 2017 to suspend Prof. Slavin's license for a period of six month [...] Justice Strashnov emphasized the seriousness of Prof. Slavin's actions, [saying] "I think that the committee went a bit too far in their punishment considerations in favor of the defendant" [...]